Medically reviewed by Jordana Haber Hazan, MD Hemolytic anemia occurs when red blood cells are destroyed faster than they can be replaced. The loss of red blood cells means that fewer are available to ...

Initial results as promising as those in lupus and other non-cancer diseases driven by B c ...

Hypomethylating agents are standard in MDS treatment, with new drugs like Rytelo enhancing anemia management. Targeted therapies for IDH1/IDH2 mutations offer promising options, though challenges in ...

Clinical stage generative artificial intelligence (AI)-driven biotechnology company InSilico Medicine ("InSilico"), today announced that the Journal of Medicinal Chemistry, an ACS Publications journal ...

By Dennis Thompson HealthDay ReporterTUESDAY, Jan. 13, 2026 (HealthDay News) — Women with iron deficiency anemia caused by ...

Mitapivat is the first FDA-approved oral therapy for anaemia in all forms of thalassemia Reduced transfusion dependence may ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that ...

Treating anemia in patients with CKD earlier, before hemoglobin levels fall below 9.0 g/dL, may reduce risks for cardiovascular events. Delaying renal anemia treatment with long-acting ...

Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be a better adjunct treatment to reduce anemia risk than glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for patients with type 2 diabetes ...

The development of new or worsening anemia did not decrease Jakafi’s efficacy in treating primary or secondary myelofibrosis. Patients with primary or secondary myelofibrosis who developed new or ...

In normochromic anemia, which is a type of blood disorder, red blood cells have typical concentrations of hemoglobin and are typical in color. It may result from underlying conditions, and treatment ...